Beth Israel Deaconess Medical Center

She is also a faculty member in the Department of Pathology and Laboratory Medicine at the Warren Alpert Medical School of Brown University.

Dr. Yu has more than a decade of leadership experience in clinical chemistry and POCT, with previous leadership appointments at the University of Kentucky and Beth Israel Deaconess Medical Center, affiliated with Harvard Medical School.

Welcome, Dr. Yu.

This is one of the first studies to benchmark POCT program support across institutions.

I'm Dr. David Ellison, Professor of Medicine and Chemical Physiology and Biochemistry at Oregon Health & Science University, and a deputy editor at the journal.

For this podcast, I'm joined by Dr. Nate Reigns of Beth Israel Deaconess Medical Center, who is one of our outstanding junior associate editors at JASN.

We're joined today by Doctors Michael Mankowski, Conor Donnelly, and Alan Massey, who are authors on an interesting clinical paper appearing in JASN this month entitled "Evaluating Barriers to Kidney Transplantation in the United States." Doctors Mankowski, Donnelly, and Massey, please introduce yourselves and tell us a little bit about your backgrounds.

Uh, hi, everyone.

He has built his career at the intersection of medicine, healthcare data, research, and technology.

Dr. Labkoff is on the faculty at the Division of Clinical Informatics at Beth Israel Deaconess Medical Center, and he co-hosts the Practical AI in Healthcare podcast.

Today, we'll explore where AI is already making a difference, where it may take us next, and some of the exciting ways it is supporting clinical decision-making and patient care.

We'll also address the questions that naturally come up with such a significant shift in medicine, a.k.a. the skepticism.

I can only imagine about the AI experience that you had.

So to give us some background here, tell us a little bit about what you're doing currently that helps you see with this insider's lens into what's going on with AI on the clinician front.

So, as you mentioned in the introduction, I'm a collaborating scientist at the Beth Israel Deaconess Medical Center's Division of Clinical Informatics.

It's a role I've played now since 2021.

The bands were still around their necks.

Cora and Dawson were pronounced dead that night at Beth Israel Deaconess in Plymouth.

Callan was flown to Boston Children's in cardiac arrest and died three days later on January 27th.

The Office of the Chief Medical Examiner ruled the cause of death for Cora and Dawson as asphyxia and for Callan complication of asphyxia.

Duxbury Fire Captain P.J. Hussey just testified at the scene, quote, turned very chaotic very quickly as more units arrived.

Ten officers, firefighters, paramedics ultimately responded.

Cora and Dawson are taken to Beth Israel Deaconess Hospital, pronounced dead.

Callen in cardiac arrest is flown to Boston Children's Hospital.

So it's an opportune time.

But there are other people with similar backgrounds, Dr. Kevin Tabb, who is the CEO at Beth Israel Deaconess Medical Center, was the CMIO at Stanford Hospital when they implemented an electronic health record.

Suresh, who is the CEO at UC San Francisco, was the CIO in Texas.

And so I think we'll increasingly see people with backgrounds in health technology, but I don't think it's actually the technology that makes the difference.